A Propensity-Matched Analysis of the Efficacy and Safety of Neoadjuvant Inetetamab and Pertuzumab with Paclitaxel and Carboplatin (tcbip) on Locally Advanced HER2-positive Breast Cancer.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined